Autor: "Cao, L." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Adipose-derived stem cell exosome NFIC improves diabetic foot ulcers by regulating miR-204-3p/HIPK2.
Autorzy:: Huang H; Burn, Plastic and Wound Surgery Department, Yichang Central People's Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Zhu W; Department of Endocrinology, Yichang Central People's Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Huang Z; Burn, Plastic and Wound Surgery Department, Yichang Central People's Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Zhao D; Burn, Plastic and Wound Surgery Department, Yichang Central People's Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Cao L; Burn, Plastic and Wound Surgery Department, Yichang Central People's Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Gao X; Burn, Plastic and Wound Surgery Department, Huanggang Central Hospital of Yangtze University, No.126, Qian Avenue, Huangzhou District, Huanggang, 438000, Hubei, China. .; Pokaż więcej
Źródło:: Journal of orthopaedic surgery and research [J Orthop Surg Res] 2023 Sep 14; Vol. 18 (1), pp. 687. Date of Electronic Publication: 2023 Sep 14.
Typ publikacji:: Journal Article
MeSH Terms:: Diabetic Foot*/genetics
Diabetic Foot*/therapy
Exosomes*
MicroRNAs*/genetics
Diabetes Mellitus*
Humans ; NFI Transcription Factors ; Endothelial Cells ; Stem Cells ; Carrier Proteins ; Protein Serine-Threonine Kinases/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: lncRNA HCG11 Promotes Colorectal Cancer Cell Malignant Behaviors via Sponging miR-26b-5p.
Autorzy:: Guo S; Department of Gastrointestinal Surgery, Binzhou Medical University Hospital, No. 661 Huanghe 2nd Road, Binzhou City, 256603 Shandong Province, China.
Song B; Department of Gastrointestinal Surgery, Binzhou Medical University Hospital, No. 661 Huanghe 2nd Road, Binzhou City, 256603 Shandong Province, China.
Li L; Operating Room, Binzhou Medical University Hospital, Binzhou City, 256603 Shandong Province, China.
Li H; Department of Gastrointestinal Surgery, Binzhou Medical University Hospital, No. 661 Huanghe 2nd Road, Binzhou City, 256603 Shandong Province, China.
Yang T; Department of Gastrointestinal Surgery, Binzhou Medical University Hospital, No. 661 Huanghe 2nd Road, Binzhou City, 256603 Shandong Province, China.
Cao L; Department of Gastrointestinal Surgery, Binzhou Medical University Hospital, No. 661 Huanghe 2nd Road, Binzhou City, 256603 Shandong Province, China.
Wang J; Department of Gastroenterology & Endoscopy, Binzhou Medical University Hospital, Binzhou City, 256603 Shandong Province, China.; Pokaż więcej
Źródło:: Journal of immunology research [J Immunol Res] 2023 Feb 23; Vol. 2023, pp. 9011232. Date of Electronic Publication: 2023 Feb 23 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: RNA, Long Noncoding*
Colorectal Neoplasms*
MicroRNAs*
Humans ; Cytoplasm ; Apoptosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: LncRNA ANRIL-mediated miR-181b-5p/S1PR1 axis is involved in the progression of uremic cardiomyopathy through activating T cells.
Autorzy:: Xu Y; Urology and Nephrology Center, Department of Urology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, China.
Cao L; Urology and Nephrology Center, Department of Nephrology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, China.
Ji S; Urology and Nephrology Center, Department of Nephrology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, China.
Shen W; Urology and Nephrology Center, Department of Nephrology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2022 Oct 27; Vol. 12 (1), pp. 18027. Date of Electronic Publication: 2022 Oct 27.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Cardiomyopathies*/pathology
MicroRNAs*/genetics
MicroRNAs*/metabolism
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
T-Lymphocytes*/metabolism
Sphingosine-1-Phosphate Receptors*/genetics
Sphingosine-1-Phosphate Receptors*/metabolism
Animals ; Mice ; Body Weight ; Cell Line ; Fibrosis ; Inflammation/pathology ; Tumor Necrosis Factor-alpha

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Inhibition of miR-652-3p Regulates Lipid Metabolism and Inflammatory Cytokine Secretion of Macrophages to Alleviate Atherosclerosis by Improving TP53 Expression.
Autorzy:: Liu H; Department of Cardiovascular, The First Affiliated Hospital of Soochow University, Suzhou 215000, China.; Department of Cardiovascular, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, Jiangsu 223002, China.
Zuo C; Department of Cardiovascular, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, Jiangsu 223002, China.
Cao L; Department of Cardiovascular, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, Jiangsu 223002, China.
Yang N; Department of Cardiovascular, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, Jiangsu 223002, China.
Jiang T; Department of Cardiovascular, The First Affiliated Hospital of Soochow University, Suzhou 215000, China.; Pokaż więcej
Źródło:: Mediators of inflammation [Mediators Inflamm] 2022 Oct 07; Vol. 2022, pp. 9655097. Date of Electronic Publication: 2022 Oct 07 (Print Publication: 2022).
Typ publikacji:: Journal Article
MeSH Terms:: Atherosclerosis*/metabolism
MicroRNAs*/metabolism
3' Untranslated Regions ; Cholesterol/metabolism ; Humans ; Interleukin-6/metabolism ; Lipid Metabolism ; Lipoproteins, LDL/metabolism ; Macrophages/metabolism ; PPAR alpha/metabolism ; Tumor Necrosis Factor-alpha/metabolism ; Tumor Suppressor Protein p53/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Emerging Roles of miRNA, lncRNA, circRNA, and Their Cross-Talk in Pituitary Adenoma.
Autorzy:: Wu W; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 119 South Forth West Ring, Beijing 100070, China.
Cao L; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 119 South Forth West Ring, Beijing 100070, China.
Jia Y; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 119 South Forth West Ring, Beijing 100070, China.
Xiao Y; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 119 South Forth West Ring, Beijing 100070, China.
Zhang X; Department of Oncology, First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Hefei 230032, China.
Gui S; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 119 South Forth West Ring, Beijing 100070, China.; Pokaż więcej
Źródło:: Cells [Cells] 2022 Sep 19; Vol. 11 (18). Date of Electronic Publication: 2022 Sep 19.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: MicroRNAs*/genetics
Pituitary Neoplasms*/genetics
RNA, Long Noncoding*/genetics
Biomarkers ; Cell Proliferation ; Humans ; RNA, Circular/genetics ; RNA, Untranslated/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: MiR-31 improves spinal cord injury in mice by promoting the migration of bone marrow mesenchymal stem cells.
Autorzy:: Zhang Y; Department of Laboratory Animal Center, Shanxi Medical University, Taiyuan, Shanxi, China.
Cao L; Department of Laboratory Animal Center, Shanxi Medical University, Taiyuan, Shanxi, China.; Department of Key Laboratory of Oral Disease Prevention and New Materials, Taiyuan, Shanxi, China.; Department of Dental Medicine, Shanxi Medical University, Taiyuan, Shanxi, China.
Du R; Department of Laboratory Animal Center, Shanxi Medical University, Taiyuan, Shanxi, China.
Tian F; Department of Key Laboratory of Oral Disease Prevention and New Materials, Taiyuan, Shanxi, China.
Li X; Department of Laboratory Animal Center, Shanxi Medical University, Taiyuan, Shanxi, China.
Yuan Y; Department of Laboratory Animal Center, Shanxi Medical University, Taiyuan, Shanxi, China.
Wang C; Department of Laboratory Animal Center, Shanxi Medical University, Taiyuan, Shanxi, China.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2022 Sep 06; Vol. 17 (9), pp. e0272499. Date of Electronic Publication: 2022 Sep 06 (Print Publication: 2022).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Mesenchymal Stem Cell Transplantation*/methods
Mesenchymal Stem Cells*/metabolism
MicroRNAs*/metabolism
Spinal Cord Injuries*/genetics
Spinal Cord Injuries*/metabolism
Spinal Cord Injuries*/therapy
Animals ; Bone Marrow Cells/metabolism ; Disease Models, Animal ; Matrix Metalloproteinase 2/genetics ; Matrix Metalloproteinase 2/metabolism ; Mice ; Rats ; Rats, Sprague-Dawley ; Spinal Cord/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Xiaotan Sanjie Decoction Inhibits Gastric Cancer Cell Proliferation, Migration, and Invasion through lncRNA-ATB and miR-200A.
Autorzy:: Zhou Z; The Second Clinical Medical College, Zhejiang Chinese Medicine University, Hangzhou 310053, Zhejiang Province, China.; Cancer Institute of Integrated Tradition Chinese and Western Medicine, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou 310012, Zhejiang Province, China.; Zhejiang Provincial Key Laboratory of Cancer Prevention and Treatment Technology of Integrated Traditional Chinese and Western Medicine, Hangzhou 310012, Zhejiang Province, China.
Chen J; The Second Clinical Medical College, Zhejiang Chinese Medicine University, Hangzhou 310053, Zhejiang Province, China.; Cancer Institute of Integrated Tradition Chinese and Western Medicine, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou 310012, Zhejiang Province, China.; Zhejiang Provincial Key Laboratory of Cancer Prevention and Treatment Technology of Integrated Traditional Chinese and Western Medicine, Hangzhou 310012, Zhejiang Province, China.
Li M; Cancer Institute of Integrated Tradition Chinese and Western Medicine, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou 310012, Zhejiang Province, China.; Zhejiang Provincial Key Laboratory of Cancer Prevention and Treatment Technology of Integrated Traditional Chinese and Western Medicine, Hangzhou 310012, Zhejiang Province, China.
Cao L; The Second Clinical Medical College, Zhejiang Chinese Medicine University, Hangzhou 310053, Zhejiang Province, China.; Cancer Institute of Integrated Tradition Chinese and Western Medicine, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou 310012, Zhejiang Province, China.; Zhejiang Provincial Key Laboratory of Cancer Prevention and Treatment Technology of Integrated Traditional Chinese and Western Medicine, Hangzhou 310012, Zhejiang Province, China.
Chen M; Cancer Institute of Integrated Tradition Chinese and Western Medicine, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou 310012, Zhejiang Province, China.; Zhejiang Provincial Key Laboratory of Cancer Prevention and Treatment Technology of Integrated Traditional Chinese and Western Medicine, Hangzhou 310012, Zhejiang Province, China.
Zhang Q; Cancer Institute of Integrated Tradition Chinese and Western Medicine, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou 310012, Zhejiang Province, China.; Zhejiang Provincial Key Laboratory of Cancer Prevention and Treatment Technology of Integrated Traditional Chinese and Western Medicine, Hangzhou 310012, Zhejiang Province, China.
Yu Z; The Second Clinical Medical College, Zhejiang Chinese Medicine University, Hangzhou 310053, Zhejiang Province, China.; Cancer Institute of Integrated Tradition Chinese and Western Medicine, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou 310012, Zhejiang Province, China.; Zhejiang Provincial Key Laboratory of Cancer Prevention and Treatment Technology of Integrated Traditional Chinese and Western Medicine, Hangzhou 310012, Zhejiang Province, China.
Chai K; The Second Clinical Medical College, Zhejiang Chinese Medicine University, Hangzhou 310053, Zhejiang Province, China.; Cancer Institute of Integrated Tradition Chinese and Western Medicine, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou 310012, Zhejiang Province, China.; Zhejiang Provincial Key Laboratory of Cancer Prevention and Treatment Technology of Integrated Traditional Chinese and Western Medicine, Hangzhou 310012, Zhejiang Province, China.; Pokaż więcej
Źródło:: BioMed research international [Biomed Res Int] 2022 Aug 25; Vol. 2022, pp. 7029182. Date of Electronic Publication: 2022 Aug 25 (Print Publication: 2022).
Typ publikacji:: Journal Article
MeSH Terms:: Drugs, Chinese Herbal*/pharmacology
MicroRNAs*/genetics
MicroRNAs*/metabolism
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Stomach Neoplasms*/drug therapy
Stomach Neoplasms*/genetics
Stomach Neoplasms*/metabolism
Cell Movement ; Cell Proliferation ; Gene Expression Regulation, Neoplastic ; Humans ; Neoplastic Processes ; Proto-Oncogene Proteins c-bcl-2/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Knockdown of circRNA Paralemmin 2 Ameliorates Lipopolysaccharide-induced Murine Lung Epithelial Cell Injury by Sponging miR-330-5p to Reduce ROCK2 Expression.
Autorzy:: Ren Y; Department of Emergency Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, PR China.
Li L; Department of Emergency Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, PR China.
Wang M; Department of Emergency Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, PR China.
Yang Z; Department of Emergency Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, PR China.
Sun Z; Department of Emergency Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, PR China.
Zhang W; Department of Emergency Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, PR China.
Cao L; Department of Emergency Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, PR China.
Nie S; Department of Emergency Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, PR China.; Pokaż więcej
Źródło:: Immunological investigations [Immunol Invest] 2022 Aug; Vol. 51 (6), pp. 1707-1724. Date of Electronic Publication: 2022 Feb 16.
Typ publikacji:: Journal Article
MeSH Terms:: Acute Lung Injury*/chemically induced
Acute Lung Injury*/genetics
MicroRNAs*/genetics
MicroRNAs*/metabolism
Animals ; Apoptosis ; Epithelial Cells/metabolism ; Lipopolysaccharides/pharmacology ; Lung/pathology ; Mice ; Mice, Inbred C57BL ; RNA, Circular/genetics ; rho-Associated Kinases/genetics ; rho-Associated Kinases/metabolism ; rho-Associated Kinases/pharmacology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Dysregulation and prometastatic function of glycosyltransferase C1GALT1 modulated by cHP1BP3/ miR-1-3p axis in bladder cancer.
Autorzy:: Tan Z; Institute of Hematology, Provincial Key Laboratory of Biotechnology, School of Medicine, Northwest University, Xi'an, 710069, People's Republic of China.
Jiang Y; Department of Urology, The Third Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710068, People's Republic of China.
Liang L; Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, People's Republic of China.
Wu J; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology, College of Life Sciences, Northwest University, 229 Taibai North Road, Xi'an, 710069, Shaanxi, China.
Cao L; Institute of Hematology, Provincial Key Laboratory of Biotechnology, School of Medicine, Northwest University, Xi'an, 710069, People's Republic of China.
Zhou X; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology, College of Life Sciences, Northwest University, 229 Taibai North Road, Xi'an, 710069, Shaanxi, China.
Song Z; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology, College of Life Sciences, Northwest University, 229 Taibai North Road, Xi'an, 710069, Shaanxi, China.
Ye Z; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology, College of Life Sciences, Northwest University, 229 Taibai North Road, Xi'an, 710069, Shaanxi, China.
Zhao Z; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology, College of Life Sciences, Northwest University, 229 Taibai North Road, Xi'an, 710069, Shaanxi, China.
Feng H; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology, College of Life Sciences, Northwest University, 229 Taibai North Road, Xi'an, 710069, Shaanxi, China.
Dong Z; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology, College of Life Sciences, Northwest University, 229 Taibai North Road, Xi'an, 710069, Shaanxi, China.
Lin S; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, People's Republic of China.
Zhou Z; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, People's Republic of China.
Wang Y; Institute for Cancer Research, School of Basic Medical Science, Health Science Center of Xi'an Jiaotong University, Xi'an, 710061, People's Republic of China.
Li X; Institute of Hematology, Provincial Key Laboratory of Biotechnology, School of Medicine, Northwest University, Xi'an, 710069, People's Republic of China. .
Guan F; Institute of Hematology, Provincial Key Laboratory of Biotechnology, School of Medicine, Northwest University, Xi'an, 710069, People's Republic of China. .; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology, College of Life Sciences, Northwest University, 229 Taibai North Road, Xi'an, 710069, Shaanxi, China. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2022 Jul 21; Vol. 41 (1), pp. 228. Date of Electronic Publication: 2022 Jul 21.
Typ publikacji:: Journal Article
MeSH Terms:: MicroRNAs*/genetics
MicroRNAs*/metabolism
Urinary Bladder Neoplasms*/pathology
3' Untranslated Regions ; Animals ; Antigens, Viral, Tumor ; Cell Line, Tumor ; Cell Movement/physiology ; Cell Proliferation ; Galactosyltransferases/genetics ; Galactosyltransferases/metabolism ; Gene Expression Regulation, Neoplastic ; Glycosyltransferases/genetics ; Glycosyltransferases/metabolism ; Humans ; Mice ; Nuclear Proteins/metabolism ; RNA, Circular

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: CircRNA circ-ATAD1 suppresses miR-618 maturation to participate in colorectal cancer.
Autorzy:: Cao L; Department of Hepatology Surgery, Department of Liver Medicine, Fifth Medical Center, General Hospital of PLA, Beijing, 100039, People's Republic of China.
Dong G; Department of General Surgery, The General Hospital of People's Liberation Army, No. 28 Fuxing Road, Haidian District, Beijing, 100853, People's Republic of China. .
Li H; Military Science Press, Beijing, 100091, People's Republic of China.; Pokaż więcej
Źródło:: BMC gastroenterology [BMC Gastroenterol] 2022 May 03; Vol. 22 (1), pp. 215. Date of Electronic Publication: 2022 May 03.
Typ publikacji:: Journal Article
MeSH Terms:: Colorectal Neoplasms*/metabolism
Colorectal Neoplasms*/pathology
MicroRNAs*/genetics
MicroRNAs*/metabolism
ATPases Associated with Diverse Cellular Activities/*genetics
Cell Line, Tumor ; Gene Expression Regulation, Neoplastic ; Humans ; RNA, Circular/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Exosomal miR-132-3p from mesenchymal stem cells alleviated LPS-induced acute lung injury by repressing TRAF6.
Autorzy:: Liu JH; Department of Respiratory Medicine, The First Affiliated Hospital of Hebei North University, Zhangjiakou, P. R. China.
Li C; Department of Respiratory Medicine, The First Affiliated Hospital of Hebei North University, Zhangjiakou, P. R. China.
Cao L; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Hebei North University, Zhangjiakou, P. R. China.
Zhang CH; Department of Respiratory Medicine, The First Affiliated Hospital of Hebei North University, Zhangjiakou, P. R. China.
Zhang ZH; Department of Respiratory Medicine, The First Affiliated Hospital of Hebei North University, Zhangjiakou, P. R. China.; Pokaż więcej
Źródło:: Autoimmunity [Autoimmunity] 2021 Dec; Vol. 54 (8), pp. 493-503. Date of Electronic Publication: 2021 Sep 17.
Typ publikacji:: Journal Article
MeSH Terms:: Acute Lung Injury*/chemically induced
Acute Lung Injury*/genetics
Acute Lung Injury*/therapy
Mesenchymal Stem Cells*/metabolism
MicroRNAs*/genetics
MicroRNAs*/metabolism
Animals ; Lipopolysaccharides/adverse effects ; Mice ; Phosphatidylinositol 3-Kinases/adverse effects ; Phosphatidylinositol 3-Kinases/genetics ; Phosphatidylinositol 3-Kinases/metabolism ; TNF Receptor-Associated Factor 6/genetics ; TNF Receptor-Associated Factor 6/metabolism

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Knockdown of circ‑PVT1 inhibits the progression of lung adenocarcinoma and enhances the sensitivity to cisplatin via the miR‑429/FOXK1 signaling axis.
Autorzy:: Cao L; Department of Respiratory Medicine, The Second People's Hospital of Lianyungang, Lianyungang, Jiangsu 222023, P.R. China.
Zhou X; Department of Oncology, The Affiliated Hospital of Nantong University, Dongtai, Jiangsu 224200, P.R. China.
Ding X; Department of Pharmacy, The Affiliated Hospital of Nantong University, Dongtai, Jiangsu 224200, P.R. China.
Gao D; Department of Oncology, The Affiliated Hospital of Nantong University, Dongtai, Jiangsu 224200, P.R. China.; Pokaż więcej
Źródło:: Molecular medicine reports [Mol Med Rep] 2021 Oct; Vol. 24 (4). Date of Electronic Publication: 2021 Jul 30.
Typ publikacji:: Journal Article
MeSH Terms:: Adenocarcinoma of Lung/*genetics
Forkhead Transcription Factors/*metabolism
Lung Neoplasms/*genetics
MicroRNAs/*metabolism
RNA, Circular/*genetics
RNA, Circular/*metabolism
A549 Cells ; Adenocarcinoma of Lung/drug therapy ; Antineoplastic Agents/pharmacology ; Apoptosis/drug effects ; Apoptosis/genetics ; Cell Movement/genetics ; Cell Proliferation/genetics ; Cisplatin/pharmacology ; Drug Resistance, Neoplasm/genetics ; Forkhead Transcription Factors/genetics ; Gene Knockdown Techniques ; Humans ; Lung Neoplasms/drug therapy ; MicroRNAs/genetics ; Signal Transduction/drug effects ; Signal Transduction/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling.
Autorzy:: Yang Q; Third Department of Breast Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Clinical Research Center for Cancer, Tianjin, China.
Zhao S; Third Department of Breast Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Clinical Research Center for Cancer, Tianjin, China.
Shi Z; Third Department of Breast Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Clinical Research Center for Cancer, Tianjin, China.
Cao L; Third Department of Breast Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Clinical Research Center for Cancer, Tianjin, China.
Liu J; Third Department of Breast Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Clinical Research Center for Cancer, Tianjin, China.
Pan T; Third Department of Breast Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Clinical Research Center for Cancer, Tianjin, China.
Zhou D; Third Department of Breast Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Clinical Research Center for Cancer, Tianjin, China.
Zhang J; Third Department of Breast Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China. .; National Clinical Research Center for Cancer, Tianjin, China. .; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China. .; Clinical Research Center for Cancer, Tianjin, China. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2021 Apr 06; Vol. 40 (1), pp. 120. Date of Electronic Publication: 2021 Apr 06.
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Agents/*pharmacology
Breast Neoplasms/*drug therapy
Enhancer of Zeste Homolog 2 Protein/*metabolism
Exosomes/*metabolism
MicroRNAs/*metabolism
STAT3 Transcription Factor/*metabolism
Animals ; Breast Neoplasms/genetics ; Breast Neoplasms/metabolism ; Cell Line, Tumor ; Cell Proliferation ; Disease Models, Animal ; Drug Resistance, Neoplasm ; Female ; Humans ; MCF-7 Cells ; Mice ; MicroRNAs/genetics ; Neoplastic Stem Cells/metabolism ; Neoplastic Stem Cells/pathology ; Xenograft Model Antitumor Assays

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Neural progenitor cell-derived nanovesicles promote hair follicle growth via miR-100.
Autorzy:: Cao L; Department of Dermatology, The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, 214000, Jiangsu, China.
Tian T; Department of Neurobiology, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
Huang Y; Department of Dermatology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, 214000, Jiangsu, China.
Tao S; Department of Dermatology, The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, 214000, Jiangsu, China.
Zhu X; Department of Dermatology, The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, 214000, Jiangsu, China.
Yang M; Jiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, 210029, Jiangsu, China.; Institute of Stomatology, The Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing, 210029, China.
Gu J; Department of Dermatology, The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, 214000, Jiangsu, China.
Feng G; Department of Dermatology, The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, 214000, Jiangsu, China.
Ma Y; Department of Dermatology, The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, 214000, Jiangsu, China.
Xia R; Department of Dermatology, The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, 214000, Jiangsu, China. .
Xu W; Department of Dermatology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, 214000, Jiangsu, China. .
Wang L; Department of Dermatology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, 214000, Jiangsu, China. .; Pokaż więcej
Źródło:: Journal of nanobiotechnology [J Nanobiotechnology] 2021 Jan 11; Vol. 19 (1), pp. 20. Date of Electronic Publication: 2021 Jan 11.
Typ publikacji:: Journal Article
MeSH Terms:: Neural Stem Cells*
Hair Follicle/*growth & development
MicroRNAs/*metabolism
Animals ; Cell Line ; Cell Proliferation/physiology ; Exosomes/metabolism ; Extracellular Vesicles ; Female ; Mice ; Mice, Inbred C57BL ; Up-Regulation ; Wnt Signaling Pathway ; beta Catenin/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: miR‑320‑3p is involved in morphine pre‑conditioning to protect rat cardiomyocytes from ischemia/reperfusion injury through targeting Akt3.
Autorzy:: Cao L; Department of Anesthesiology, Tiantai People's Hospital of Zhejiang Province, Tiantai, Zhejiang 317200, P.R. China.
Chai S; Department of Orthopedics, Tiantai People's Hospital of Zhejiang Province, Tiantai, Zhejiang 317200, P.R. China.; Pokaż więcej
Źródło:: Molecular medicine reports [Mol Med Rep] 2020 Aug; Vol. 22 (2), pp. 1480-1488. Date of Electronic Publication: 2020 May 27.
Typ publikacji:: Journal Article
MeSH Terms:: MicroRNAs/*metabolism
Morphine/*pharmacology
Myocardial Reperfusion Injury/*prevention & control
Myocytes, Cardiac/*metabolism
Protective Agents/*pharmacology
Proto-Oncogene Proteins c-akt/*metabolism
Animals ; Apoptosis/drug effects ; Binding Sites ; Cell Line ; Computational Biology ; L-Lactate Dehydrogenase/metabolism ; Luciferases/chemistry ; MicroRNAs/drug effects ; MicroRNAs/genetics ; Morphine/administration & dosage ; Myocardial Reperfusion Injury/genetics ; Myocardial Reperfusion Injury/metabolism ; Myocytes, Cardiac/drug effects ; Phosphatidylinositol 3-Kinases/metabolism ; Protective Agents/administration & dosage ; Proto-Oncogene Proteins c-akt/drug effects ; Proto-Oncogene Proteins c-akt/genetics ; Rats ; Signal Transduction/drug effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Role of miR-155-5p expression and its involvement in apoptosis-related factors in thyroid follicular carcinoma.
Autorzy:: Geng X; Department of Thyroid and Breast Surgery, Changzhou No.2 People's Hospital Affiliated to Nanjing Medical University, Changzhou, China.
Sun YY; Department of Pathology, Changzhou No.2 People's Hospital Affiliated to Nanjing Medical University, Changzhou, China.
Fu JJ; Department of Gastroenterology, Changzhou No.2 People's Hospital Affiliated to Nanjing Medical University, Changzhou, China.
Cao L; Department of General Surgery, Changzhou No.2 People's Hospital Affiliated to Nanjing Medical University, Changzhou, China.
Li Y; Department of Thyroid and Breast Surgery, Changzhou No.2 People's Hospital Affiliated to Nanjing Medical University, Changzhou, China.; Pokaż więcej
Źródło:: Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2020 Aug; Vol. 45 (4), pp. 660-665. Date of Electronic Publication: 2020 May 15.
Typ publikacji:: Journal Article
MeSH Terms:: Adenocarcinoma, Follicular/*genetics
Apoptosis/*genetics
MicroRNAs/*genetics
Thyroid Neoplasms/*genetics
Adult ; Aged ; Aged, 80 and over ; Caspase 3/genetics ; Cell Proliferation/genetics ; Female ; Humans ; Lymphatic Metastasis/genetics ; Male ; Middle Aged ; Thyroid Gland/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Linc02349 promotes osteogenesis of human umbilical cord-derived stem cells by acting as a competing endogenous RNA for miR-25-3p and miR-33b-5p.
Autorzy:: Cao L; NHC Key Laboratory of Carcinogenesis, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.; School of basic Medical Science, Central South University, Changsha, China.; The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, Central South University, Changsha, China.
Liu W; Institute of Metabolism and Endocrinology, Nation Clinical Research Center for Metabolic Diseases, The Second XiangYa Hospital, Central South University, Changsha, China.
Zhong Y; NHC Key Laboratory of Carcinogenesis, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.; School of basic Medical Science, Central South University, Changsha, China.
Zhang Y; NHC Key Laboratory of Carcinogenesis, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.; School of basic Medical Science, Central South University, Changsha, China.
Gao D; NHC Key Laboratory of Carcinogenesis, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.; School of basic Medical Science, Central South University, Changsha, China.
He T; NHC Key Laboratory of Carcinogenesis, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.; School of basic Medical Science, Central South University, Changsha, China.
Liu Y; NHC Key Laboratory of Carcinogenesis, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.; School of basic Medical Science, Central South University, Changsha, China.
Zou Z; NHC Key Laboratory of Carcinogenesis, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.; School of basic Medical Science, Central South University, Changsha, China.
Mo Y; NHC Key Laboratory of Carcinogenesis, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.; School of basic Medical Science, Central South University, Changsha, China.
Peng S; NHC Key Laboratory of Carcinogenesis, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.; School of basic Medical Science, Central South University, Changsha, China.; The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, Central South University, Changsha, China.
Shuai C; Institute of Bioadditive Manufacturing, Jiangxi University of Science and Technology, Nanchang, China.; State Key Laboratory of High Performance Complex Manufacturing, Central South University, Changsha, China.; Pokaż więcej
Źródło:: Cell proliferation [Cell Prolif] 2020 May; Vol. 53 (5), pp. e12814. Date of Electronic Publication: 2020 Apr 29.
Typ publikacji:: Journal Article
MeSH Terms:: Mesenchymal Stem Cells/*pathology
MicroRNAs/*genetics
Osteogenesis/*genetics
RNA, Long Noncoding/*genetics
Umbilical Cord/*pathology
Cell Differentiation/genetics ; Cells, Cultured ; HEK293 Cells ; Humans ; Osteoblasts/pathology ; Promoter Regions, Genetic/genetics ; STAT3 Transcription Factor/genetics ; Transcription, Genetic/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer.
Autorzy:: Ge P; Department of Cardiac & Thoracic Surgery, Second Affiliated Hospital of Xi'an Medical University, Xi'an, 710038, People's Republic of China.
Cao L; Department of Gynecology, Second Affiliated Hospital of Xi'an Medical University, Xi'an, 710038, People's Republic of China.
Chen X; Department of Cardiac & Thoracic Surgery, Second Affiliated Hospital of Xi'an Medical University, Xi'an, 710038, People's Republic of China.
Jing R; Department of Cardiac & Thoracic Surgery, Second Affiliated Hospital of Xi'an Medical University, Xi'an, 710038, People's Republic of China.
Yue W; Department of Pathology, Second Affiliated Hospital of Xi'an Medical University, No.167 Fangdong Avenue, Baqiao District, Xi'an, 710038, Shaanxi Province, People's Republic of China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2019 Dec 10; Vol. 19 (1), pp. 1203. Date of Electronic Publication: 2019 Dec 10.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung/*drug therapy
Drug Resistance, Neoplasm/*genetics
Gefitinib/*therapeutic use
Lung Neoplasms/*drug therapy
MicroRNAs/*genetics
Protein Kinase Inhibitors/*therapeutic use
Animals ; Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Non-Small-Cell Lung/mortality ; Cell Line, Tumor ; Cell Survival ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/genetics ; Female ; GTPase-Activating Proteins/genetics ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Interleukin-6/genetics ; Interleukin-6/metabolism ; Lung Neoplasms/genetics ; Lung Neoplasms/mortality ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Middle Aged ; Mutation ; Signal Transduction/drug effects ; Xenograft Model Antitumor Assays

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: LncRNA FOXD2-AS1 induces chondrocyte proliferation through sponging miR-27a-3p in osteoarthritis.
Autorzy:: Wang Y; a Department of Emergency, Changhai Hospital , Second Military Medical University , Shanghai , China.; b Department of Orthopedics, Changhai Hospital , Second Military Medical University , Shanghai , China.
Cao L; c Department of Trauma and Orthopedics, Shanghai General Hospital , Shanghai Jiaotong University , Shanghai , China.
Wang Q; c Department of Trauma and Orthopedics, Shanghai General Hospital , Shanghai Jiaotong University , Shanghai , China.
Huang J; c Department of Trauma and Orthopedics, Shanghai General Hospital , Shanghai Jiaotong University , Shanghai , China.
Xu S; a Department of Emergency, Changhai Hospital , Second Military Medical University , Shanghai , China.; b Department of Orthopedics, Changhai Hospital , Second Military Medical University , Shanghai , China.; Pokaż więcej
Źródło:: Artificial cells, nanomedicine, and biotechnology [Artif Cells Nanomed Biotechnol] 2019 Dec; Vol. 47 (1), pp. 1241-1247.
Typ publikacji:: Journal Article
MeSH Terms:: Chondrocytes/*pathology
MicroRNAs/*genetics
Osteoarthritis/*genetics
Osteoarthritis/*pathology
RNA, Long Noncoding/*genetics
Cell Line ; Cell Proliferation/genetics ; Disease Progression ; Extracellular Matrix/metabolism ; Gene Expression Regulation ; Humans ; Toll-Like Receptor 4/genetics

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Whole-transcriptome RNA sequencing reveals the global molecular responses and ceRNA regulatory network of mRNAs, lncRNAs, miRNAs and circRNAs in response to copper toxicity in Ziyang Xiangcheng (Citrus junos Sieb. Ex Tanaka).
Autorzy:: Fu XZ; Citrus Research Institute, Southwest University, Chongqing, 400712, China. .; Citrus Research Institute, Chinese Academy of Agricultural Sciences, Chongqing, 400712, China. .
Zhang XY; Citrus Research Institute, Southwest University, Chongqing, 400712, China.; Citrus Research Institute, Chinese Academy of Agricultural Sciences, Chongqing, 400712, China.
Qiu JY; Citrus Research Institute, Southwest University, Chongqing, 400712, China.; Citrus Research Institute, Chinese Academy of Agricultural Sciences, Chongqing, 400712, China.
Zhou X; Citrus Research Institute, Southwest University, Chongqing, 400712, China.; Citrus Research Institute, Chinese Academy of Agricultural Sciences, Chongqing, 400712, China.
Yuan M; Citrus Research Institute, Southwest University, Chongqing, 400712, China.; Citrus Research Institute, Chinese Academy of Agricultural Sciences, Chongqing, 400712, China.
He YZ; Citrus Research Institute, Southwest University, Chongqing, 400712, China.; Citrus Research Institute, Chinese Academy of Agricultural Sciences, Chongqing, 400712, China.
Chun CP; Citrus Research Institute, Southwest University, Chongqing, 400712, China.; Citrus Research Institute, Chinese Academy of Agricultural Sciences, Chongqing, 400712, China.
Cao L; Citrus Research Institute, Southwest University, Chongqing, 400712, China.; Citrus Research Institute, Chinese Academy of Agricultural Sciences, Chongqing, 400712, China.
Ling LL; Citrus Research Institute, Southwest University, Chongqing, 400712, China.; Citrus Research Institute, Chinese Academy of Agricultural Sciences, Chongqing, 400712, China.
Peng LZ; Citrus Research Institute, Southwest University, Chongqing, 400712, China. .; Citrus Research Institute, Chinese Academy of Agricultural Sciences, Chongqing, 400712, China. .; Pokaż więcej
Źródło:: BMC plant biology [BMC Plant Biol] 2019 Nov 21; Vol. 19 (1), pp. 509. Date of Electronic Publication: 2019 Nov 21.
Typ publikacji:: Journal Article
MeSH Terms:: Transcriptome*
Citrus/*genetics
Copper/*toxicity
MicroRNAs/*genetics
RNA, Circular/*genetics
RNA, Untranslated/*genetics
Citrus/drug effects ; Gene Ontology ; Gene Regulatory Networks/drug effects ; RNA, Messenger/genetics ; RNA, Plant/genetics ; Sequence Analysis, RNA

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Cao, L."" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język